arrow
H

Harald Mischak

mosaiques diagnostics
H指数:98
被引数:3.3万

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Urinary peptidomic signature for non-invasive diagnosis of Alport syndrome in children

儿童Alport综合征非侵入性诊断的尿液肽组学特征

2026-09-250
OA
Urinary collagen type I degradation products as common fibrosis biomarkers in chronic diseases

尿液中I型胶原降解产物作为慢性疾病中共同的纤维化生物标志物

2026-09-230
OAAI
Prospective validation of a urine-based proteomics test for predicting clinically significant prostate cancer in biopsy-naïve patients

基于尿液的蛋白质组学检测预测活检初治患者临床显著前列腺癌的前瞻性验证

2026-08-290
PRE
Post-Acute Sequelae of COVID-19 (PASC) in Hospitalized and Ambulatory Patients: A Comparative Study

COVID-19急性期后后遗症(PASC)在住院和门诊患者中的比较研究

2026-05-120
OAAI
Urinary Collagen Peptides Predict Mortality

尿胶原肽预测死亡率

2026-04-090
OA
Evaluation of race-free eGFR equations in individuals of different ethnicity

对不同种族个体中无种族因素的eGFR方程的评估

2025-12-310
PRE
Urinary Peptidomic Profiling In Post-Acute Sequelae of SARS-CoV-2 Infection: A Case-Control Study

SARS-CoV-2感染后急性期后遗症的尿液肽组学分析:一项病例对照研究

2025-11-010
OAAI
Corrigendum to “Dietary glycocalyx mimetic reduces vascular risk in Type 2 diabetes: evidence from urinary peptidomic classifiers in a South–Asian Surinamese Cohort”. [DIAB 229 (2025) 112931]

勘误:“饮食性糖萼模拟物可降低2型糖尿病的血管风险:来自南亚苏里南人群尿肽组分类器的证据”。[DIAB 229 (2025) 112931]

2025-10-250
OAAI